In 2011 this blog was listed as one of the top 10 blog in pharma technical information it is popular amongst the pharmacists and pharma industry professionals. We have published very important and very useful information for pharma industry professionals.

Thursday, July 21, 2011

New class of antidiabetic drugs which lower blood glucose by urinary excretion of glucose.

Anti diabetic drug which could lower blood glucose level by passing out blood glucose in urine.
Diabetes is a condition where sugar level in blood is not controlled by our body because of which a constant high blood sugar level becomes prime health damaging factor for person affected with diabetes.

What if blood glucose is eliminated out of our body through urine ?

Increased blood glucose level in diabetes make patient susceptible to further complications like nerve damage and kidney failure, heart disease and stroke.

Pharmaceutical companies have developed such drugs and unfortunately one of such drug got disapproved , was about to hit US market soon, it got disapproved by US FDA as there were few cases wherein patients participated in the clinical trials were found to be affected with cancer.

It could have been possible to treat both types of diabetes type 1 diabetes and type 2 diabetes patients as well as patients which do not respond to insulin with such antidiabetic drug.

The drug name is Dapagliflozin a SGLT2 inhibitor drug which is an experimental (new drug application) (NDA), diabetes once a day pill being developed jointly by pharmaceutical companies Bristol-Myers Squibb and AstraZeneca.

9 Cases of bladder cancer were observed out of 5,478 patients treated with this drug. Compared to a only one case of bladder cancer in control study group of 3,156 patients.
Six patients out of these 10 patients were found to develop hematuria (blood in the urine).

9 women out of 2,223 women treated with the drug were found to be affected with breast cancer.

As the drug leads to elimination of glucose though urine , high concentration of glucose is responsible for urinary tract infection as well.

Each and every drug which apply for permission for marketing in United States is required to exhibit through prompt clinical trials on human volunteers that it does not pose any safety risks to patients, there are no side effects or if at all are not so serious, further more it is also required that the efficacy of the new drug is also superior to the present marketed drugs which are used for same indication(s).

Mode of action of SGLT2 inhibitor anti diabetic drugs:


SGLT2 inhibitor drug act by inhibiting enzymes and proteins system sodium-glucose co-transporter 2 (SGLT2) which is responsible for reabsorption of glucose from kidney’s proximal tubules, inhibiting the protein and enzyme system SGLT2 leads to increased excretion of glucose molecule through urine.

The drug may not be effective in diabetes patients suffering from kidney failure; they would require conventional antidiabetic drugs.

Nanoparticles of insulin in place of painful injections in treatment for diabetes patients, transdermal , nasal drug delivery systems



1 comment:

Anonymous said...

Good invention but the drug must be safe then it will be useful .
US FDA is very perticular about the safty americans should thank them


What is 21 CFR Part 11, US FDA guidelines requirements of FDA compliance and CFR 21 Part 11.

What is a Site Master file of a pharmaceutical company

What is Generic Drug

What is Reference Listed Drug  ? ( RLD )

What is Pharmaceutical Equivalents

What is Pharmaceutical Alternatives

What is Therapeutic Equivalents

What are Post Market studies

Why a drug is bound to protein, What is protein binding?  What is drug absorption , distribution ?

Do Physical properties contribute to drug activity.

What is drug receptor , How a drug resistance occurs

Mechanism of drug resistance

What is drug interaction

Drug interaction, and its examples

What is first pass metabolism of a drug

What is What is 510(k) Clearances ?

What is 510(k) Clearances,

Premarket Notification for medical devices - PMN or 510(k)

What is a drug interaction

Examples of drug interactions


Antibiotic Definition and classification


Antibiotic Resistance and Antibiotic resistance mechanism

Antioxidants food supplements

Vitamin D Details on FDA cautions on accurate dosage of Vitamin D


What is an antibody? what is monoclonal and polyclonal antibodies?

Terminologies In vaccine Production

Multi stage testing of Virus vaccine production

Testing of vaccines at different stages of production

TESTING FOR ADVENTITIOUS AGENTS CELL PROPERTIES IN VIRAL VACCINE PRODUCTION

Enzyme linked immunosorbent assay ELISA

Raido Immuno assay

http://whoguideline.blogspot.com/2010/04/terminalogy-and-their-explanations.html

Pharmaceutical Aseptic Manufacturing Process Terms , Terminology and Definitions.

http://whoguideline.blogspot.com/2010/02/pharmaceutical-aseptic-manufacturing.html

Here are some articles which will be useful for you in further understanding of aspects of sterile dosage form manufacturing and regulatory affairs and good manufacturing practice in

pharmaceutical industry

Pharmaceutical Validation

Types of validations in pharmaceutical manufacturing


Requirements of documents for validation of sterilisation process

How to investigate OOS out of specification results

Determination of Phenol coefficient of a disinfectant

Sterility testing

Clean Room Classification

Time limitations in sterile pharmaceuticals processing

Aspects of validation of manufacturing process in sterile pharmaceuticals

Clinical Trials

Requirements of US FDA Inspections of Clinical Investigators of Clinical Trials

PROCEDURE OF AN INSPECTIONS OF CLINICAL TRIAL INVESTIGATOR BY US FDA HOW ARE CLINICAL INVESTIGATOR INSPECTIONS CONDUCTED?

US FDA INSPECTION OF CLINICAL INVESTIGATORS OUT OF UNITED STATES OF AMERICA

REPORTS AFTER AN INSPECTION OF A INVESTIGAOTR OF CLINICAL TRIALS

Controlling Pyrogens in injectable dosage forms

Media fill run process simulation aspects Validation of Aseptic Process and Sterilisation

New Drug Application (NDA) how to make a New Drug Application (NDA) to US FDA

Abbreviated New Drug Application (ANDA) What is ANDA , detailed information about ANDA preparation and submission to US FDA

How to make Investigational New Drug (IND) Application to US FDA

Drug applications submission to us fda Over the counter Drugs OTC drugs

BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS

Electronic record in pharmaceutical manufacturing industry

Good manufacturing practice in pharmaceutical industry

Pharmaceutical industry pharmaceutical companies and FDA latest updates